👉👉👉It’s time to talk about revised endpoints for Myelofibrosis clinical trials in the new era of novel tx. 📣 We must move beyond/add to spleen+sxs. ➡️We must focus on OS, PFS, EFS,blast % improvement,anemia improvement, bridge to alloSCT #MPNSM
Adam Mead Claire Harrison

This study explored resident perspectives across 3 domains: motivation for obtaining entrustable professional activities (EPAs), perceived importance of EPAs, and overall thoughts on the competency based medical education (CBME) curriculum bit.ly/3vXnDSP #MedEd

Congratulations to our fellows ⁦Samuel Kareff, MD, MPH⁩ ⁦Asaad Trabolsi for leading this comprehensive review ⁩ | The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors ⁦gilberto lopes⁩ ⁦⁦Caris Life Sciences⁩ mdpi.com/2072-6694/16/8…

How do you evaluate the evaluators and at scale? This article details a novel #ArtificialIntelligence based approach toward automatic #assessment of narrative feedback quality developed and tested at 2 residency programs: ow.ly/sYlf50R6T0Y. #MedEd Rob Woods (he/him)

Vol 2 of our MedEd CoP Newsletter just dropped! 📰
Featuring upcoming virtual events, summary of our inaugural MedEd Mentorship Program, and overview of events planned at #ASCO24 ! View it here, or download from the ASCO Connection community page! #oncmeded #meded #Oncology

Cool programming from @ACGME - #MedEd Journal Club!

Had a blast attending my first #AACR2024 annual meeting and presenting our work on the #TEM8 receptor, an attractive target in Neuroendocrine Neoplasms (NENs, including #NETs )

Stay tuned for Phase 1 trial! 💊

Media: news.med.miami.edu/combining-immu…

Review: pubmed.ncbi.nlm.nih.gov/37998358/

Want a behind-the-scenes look at #peerreview ? Register for this free 4/18 webinar with speakers who hold roles as editors and reviewers: ow.ly/b7wl50R6O0T. #MedEd #scholarlypublishing MedEdPORTAL

Communities of Practice such as the ASCO OncMedEdCoP are wonderful opportunities for trainees (med students, residents, fellows), too! Sign up on ASCO MyConnection. myconnection.asco.org

Zoom link for our virtual networking event now LIVE! Check the MedEd CoP page on ASCO Connections for details! 🚨🚨
tinyurl.com/MyConnection-M…

Save the date! Join the #MedEd CoP for a virtual networking event on Tues, April 16 at 2pm PT / 5pm ET! Hosted by Sam Brondfield, MedEd CoP Chair. Zoom link coming soon on the ASCO Connection page! Stay tuned! #OncMedEd Sam Brondfield, MD, MAEd Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Lori Rosenstein, MD Liza Henry McDonald

Travis J. Osterman, DO, takes a pragmatic approach to the near-term opportunities and risks to AI and LLMs in oncology. Travis Osterman, DO, MS, FAMIA, FASCO Vanderbilt-Ingram Cancer Center @vumchealth #oncology onclive.com/view/how-to-ma…

Also this #CancerResearch resulted in Chris Cann, MD receiving the @asco annual meeting 2022 merit award 👏🏻👏🏻 !! Fox Chase Cancer Center Vanderbilt-Ingram Cancer Center

Glad to be part of this important real world study led by Onyee Chan Dr. Lancet Rami komrokji Moffitt Cancer Center

Great job💪🏻💙👏🏻🙏🏻 Dr. jordan berlin and TEAM Vanderbilt-Ingram Cancer Center for #nashville #strollinforthecolon turnout! #CommunityEngagement #cancer #cancer awareness #coloncancerawareness Dr. Cathy Eng Laura Goff Kristen Ciombor Colon Cancer Coalition #Youngadultcancers

congratulations Bipin Savani VUMC Department of Medicine Vanderbilt Hem / Onc Vanderbilt-Ingram Cancer Center

Congratulations Bipin Savani!!!
He is THE BEST!
Honored to celebrate Dr. Savani’s receipt of the Lifetime Achievement Award. His unparalleled dedication and contributions to #BMTsm #CART have not only advanced our knowledge but also inspired countless individuals.
Bhagirath Dholaria, MD

Dr Dholaria Bhagirath Dholaria, MD presenting #Tandem24 Vanderbilt-Ingram Cancer Center Vanderbilt Internal Medicine Residency Vanderbilt Hem / Onc Vanderbilt Health Reena Jayani Ola Oluwole Adetola Kassim Dr. jordan berlin

BMT legend Bipin Savani on the impact of inspiring the next generation at #Tandem24 ❤️🙏

Excited to see this published in NEJM. Phase 2 results of REVIVE - studying the efficacy of the hepcidin mimetic, rusfertide in phlebotomy dependent patients with PV. #MPNSM . Phase 3 VERIFY study is ongoing. Naveen Pemmaraju, MD Aaron Gerds MD, MS Jeanne M Palmer Abdulraheem Yacoub Moffitt Cancer Center